Search results
Results from the WOW.Com Content Network
Childhood-onset systemic lupus erythematosus (i.e., cSLE), also termed juvenile-onset systemic lupus erythematosus, juvenile systemic lupus erythematosus, and pediatric systemic lupus erythematosus, is a form of the chronic inflammatory and autoimmune disease, systemic lupus erythematosus (i.e., SLE), that develops in individuals up to 18 years old. [1]
Discoid lupus erythematosus is the most common type of chronic cutaneous lupus (CCLE), an autoimmune skin condition on the lupus erythematosus spectrum of illnesses. [ 1 ] [ 2 ] It presents with red, painful, inflamed and coin-shaped patches of skin with a scaly and crusty appearance, most often on the scalp, cheeks, and ears.
The original buildings date to 1932, with additional buildings completed in 1937, 1945, and 1946. A major expansion occurred in the 1970s. In 1978, President Jimmy Carter named the hospital after U.S. Representative from South Carolina, William Jennings Bryan Dorn. [2] The complex includes the hospital, recreation, dining, and residential ...
Chilblain lupus erythematosus is characterized by a rash that primarily affects acral surfaces that are frequently exposed to cold temperatures, such as the toes, fingers, ears, and nose. The rash is defined by oedematous skin, nodules , and tender plaques with a purple discoloration.
Tumid lupus erythematosus is a rare, but distinctive entity in which patients present with edematous erythematous plaque. [ 2 ] Lupus erythematosus tumidus (LET) was reported by Henri Gougerot and Burnier R. in 1930.
Lupus vasculitis typically indicates a dismal prognosis, so early diagnosis is essential to a successful outcome. [2] The disease can affect small vessels or a single organ, and it can range in severity from a relatively mild condition to a multiorgan system disease with potentially fatal symptoms, like mesenteric vasculitis, [ 3 ] pulmonary ...
Drug-induced lupus erythematosus is an autoimmune disorder caused by chronic use of certain drugs. These drugs cause an autoimmune response (the body attacks its own cells) producing symptoms similar to those of systemic lupus erythematosus (SLE).
Daniel Jeffrey Wallace (born October 27, 1949) is an American rheumatologist, clinical professor, author, and fellow. [1] Wallace has published 500 peer reviewed publications, 9 textbooks, and 28 book chapters on topics such as lupus, Sjögren syndrome, osteoarthritis, and fibromyalgia. [2]